Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.31 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12122432 | 1.00 | ALDH1A1 (0.33) | ALDH1A1TSHRMAPK1RNPEPSLC7A5 | |
| SCHEMBL11352423 | 1.00 | ALDH1A1 (0.33) | ALDH1A1TSHRMAPK1RNPEPSLC7A5 | |
| SCHEMBL12122478 | 1.00 | ALDH1A1 (0.33) | ALDH1A1TSHRMAPK1RNPEPSLC7A5 | |
| SCHEMBL1329632 | 0.94 | — | — | |
| SCHEMBL1329633 | 0.94 | — | — | |
| SCHEMBL12122420 | 0.94 | — | — | |
| SCHEMBL1977880 | 0.87 | — | — | |
| SCHEMBL23846021 | 0.83 | TSHR (0.44) | ALDH1A1TSHRMAPK1RNPEPSLC7A5 | |
| SCHEMBL31380967 | 0.83 | TSHR (0.44) | ALDH1A1TSHRMAPK1RNPEPSLC7A5 | |
| SCHEMBL19819960 | 0.83 | TSHR (0.44) | ALDH1A1TSHRMAPK1RNPEPSLC7A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110282075-A1 | METHOD FOR PREPARING VITTATALACTONE | ALBERT-LUDWIGS-UNIVERSITAT FREIBURG (DE) | 2011-11-17 | — | — | US | disclosed |
| US-20110282075-A1 | METHOD FOR PREPARING VITTATALACTONE | ALBERT-LUDWIGS-UNIVERSITAT FREIBURG (DE) | 2011-11-17 | — | — | US | disclosed |
| US-20110282075-A1 | METHOD FOR PREPARING VITTATALACTONE | ALBERT-LUDWIGS-UNIVERSITAT FREIBURG (DE) | 2011-11-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110282075-A1 | METHOD FOR PREPARING VITTATALACTONE | FNTA, LCAT, AAAS | ALDH1A1 2817/4885TSHR 3770/4885MAPK1 4407/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.